Bionomous
PrivateLast Round
Series A
Jan 20, 2023
Total Funding Raised
$4.39M
Company Overview
Bionomous operates in Healthcare & Life Sciences and is based in Villaz-Saint-Pierre. Its latest recorded funding round was a Series A round in January 2023.
Bionomous is a life sciences technology company that provides automated, AI-powered solutions for the screening, sorting, and plating of small biological entities.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Biotechnology, Computer Vision, Industrial Robotics
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bionomous Comparables
Compare Bionomous with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nagi Bioscience SA | 83% | |
| Union Biometrica, Inc. | 81% | |
| Phylumtech S.A. | 78% |
For institutional investors. Book with your work email.
Bionomous Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 20, 2023 | ||||
| Seed | Sep 9, 2021 | ||||
| Grant | Nov 20, 2020 | ||||
| Debt | Jan 28, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Bionomous Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cybernetix Ventures | Series A |
| Foundation for Technological Innovation | Debt |
| Capital Risque Fribourg | Series A |
| Swiss ICT Investor Club | Seed |
| Venture Kick | Seed, Grant |
| Nivalis Group | Series A, Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
Monthly visitors increased 44% MoM.
- Apr 8, 2025
Raghu Behara appointed to lead commercial strategy and partnerships.
For institutional investors. Book with your work email.
Bionomous Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Bionomous's valuation, stock price, and market status.
Is Bionomous a public or private company?
Bionomous is a private company.
What is the current stock price of Bionomous?
Bionomous is a private company, so its shares have no public market price. Caplight tracks Bionomous's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Bionomous worth (valuation)?
Valuation information for Bionomous is not publicly available.
Can I buy Bionomous stock?
Bionomous shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Bionomous's last funding round?
Bionomous's most recent funding round was Series A on January 20, 2023.
Who are the main investors in Bionomous?
Key investors in Bionomous include Nivalis Group.
Will Bionomous IPO soon?
No public IPO plans have been announced for Bionomous.
How can I track Bionomous secondary market activity?
Caplight tracks bids, offers, and trades in Bionomous's shares on secondary markets.